Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Pol J Vet Sci ; 23(2): 235-245, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32627979

RESUMEN

Emerging researches in humans, pigs and mice, highlighted that estrogen plays a pivotal role in self-renewal and differentiation of bone marrow mesenchymal stem cells (BMSCs). The present study aimed at evaluating effects of 17 beta-estradiol (E2) on proliferation and apop-tosis of canine-derived bone marrow mesenchymal stem cells (cBMSCs) in vitro. The results showed that E2 supplementation at the concentration of 10-11 M promoted the proliferation of cBMSCs by CCK-8 assay and RT-qPCR analysis for the proliferation-related genes, with proliferating cell nuclear antigen (PCNA), cyclin-D1 (CCND1) being up-regulated and cyclin--dependent kinase inhibitor 1B (CDKN1B) being down-regulated. Contrarily, analysis of fluores-cence-activated cell sorting (FACS) and RT-qPCR demonstrated that E2 supplementation above 10-11 M had inhibitory effects on the proliferation of cBMSCs and induced apoptosis. Intriguingly,cBMSCs still possessed the capability to differentiate into osteoblasts and adipocytes with 10-11 M E2 addition. Taken together, this study determined the optimal culture condition of cBMSCs in vitro, and has important implications for further understanding the regulatory effect of E2 on the self-renewal of cBMSCs, which are helpful for the clinical application of BMSCs.


Asunto(s)
Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Estradiol/farmacología , Células Madre Mesenquimatosas/efectos de los fármacos , Células Madre Mesenquimatosas/fisiología , Animales , Perros , Estrógenos/farmacología
3.
Eur Rev Med Pharmacol Sci ; 23(24): 10851-10866, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31858554

RESUMEN

OBJECTIVE: Distant metastasis or local recurrence is the leading cause of death in some patients with thyroid cancer (TC), a malignant tumor of the endocrine system. Circular RNA circ_0067934 (circ_0067934) has been reported to be connected with the tumorigenesis of multiple tumors. However, there are few reports on the role and regulatory mechanisms of circ_0067934 in TC. MATERIALS AND METHODS: The expression levels of circ_0067934, protein kinase C iota (PRKCI), microRNA-1304 (miR-1304), and C-X-C chemokine receptor types 1 (CXCR1) were detected with quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The proliferation, apoptosis, migration, and invasion of TC cells were evaluated by Cell Counting Kit-8 (CCK8) assay, flow cytometry assay, and transwell assay, respectively. The relationship between circ_0067934 or CXCR1 and miR-1304 was confirmed with Dual-Luciferase reporter assay or RNA immunoprecipitation (RIP) assay. Protein level of CXCR1 was analyzed via Western blot analysis. Xenograft assay was executed to verify the role of circ_0067934 in vivo. RESULTS: Circ_0067934 and CXCR1 were enhanced and miR-1304 decreased in TC tissues and cells. Circ_0067934 downregulation triggered apoptosis and curbed proliferation, migration, and invasion of TC cells in vitro, as well as repressed tumor growth in vivo. Notably, circ_0067934 regulated CXCR1 expression via sponging miR-1304 in TC cells. Both miR-1304 silencing and CXCR1 elevation reversed the facilitation of apoptosis and the retardation of proliferation, migration, and invasion induced by circ_0067934 reduction in TC cells. CONCLUSIONS: Circ_0067934 downregulation expedited apoptosis and retarded proliferation, migration, and invasion of TC cells through miR-1304/CXCR1 axis.


Asunto(s)
Apoptosis , MicroARNs/metabolismo , ARN Circular/metabolismo , Receptores de Interleucina-8A/metabolismo , Neoplasias de la Tiroides/metabolismo , Movimiento Celular , Proliferación Celular , Humanos , MicroARNs/genética , ARN Circular/genética , Receptores de Interleucina-8A/genética , Neoplasias de la Tiroides/genética , Neoplasias de la Tiroides/patología
5.
Genet Mol Res ; 14(4): 14216-28, 2015 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-26600479

RESUMEN

The giant panda (Ailuropoda melanoleuca) is one of the world's most endangered mammals, and it has evolved several unusual biological and behavioral traits. During puberty, pregnancy, lactation, and involution, the mammary gland undergoes profound morphological and functional changes. A large number of microRNAs (miRNAs) have been identified to be involved in mammary gland development and lactation. In this study, we identified 202 conserved mature miRNAs, corresponding to 147 pre-miRNAs, in giant panda peripheral blood using a small RNA-sequencing approach. In addition, 27 miRNA families and 29 miRNA clusters were identified. We analyzed the arm selection preference of pre-miRNAs and found that: 1) most giant panda pre-miRNAs generated one-strand miRNAs, and the 5p-arm only miRNAs have a higher expression level than 3p-arm only miRNAs; 2) there were more 5p-arm dominant miRNAs than 3p-arm dominant miRNAs; and 3) 5p-arm dominant miRNAs have a larger fold change within miRNA pairs than 3p-arm dominant miRNAs. Expression of 12 lactation-related miRNAs was detected across late pregnancy and early lactation stages by qPCR, and seven miRNAs were identified as clustered in one significant model. Most of these clustered miRNAs exhibited inhibitory roles in proliferation and differentiation of mammary epithelial cells. Functional analysis highlighted important roles of the seven as signed miRNAs in mammary development and metabolic changes, including blood vessel morphogenesis, macromolecule biosynthesis, cell cycle regulation, and protein transport.


Asunto(s)
Lactancia/genética , Glándulas Mamarias Animales/fisiología , MicroARNs/sangre , Preñez/genética , Ursidae/genética , Animales , Femenino , Perfilación de la Expresión Génica/veterinaria , Glándulas Mamarias Animales/metabolismo , MicroARNs/genética , Embarazo , Preñez/sangre , Reacción en Cadena en Tiempo Real de la Polimerasa , Análisis de Secuencia de ARN/métodos , Maduración Sexual/genética , Ursidae/sangre
6.
Genet Mol Res ; 14(1): 2647-53, 2015 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-25867413

RESUMEN

The goal of this study was to investigate damaged liver function after chemotherapy in hepatitis B virus (HBV) carriers with non-Hodgkin lymphoma (NHL) and to evaluate risk factors associated with a high risk of damaged liver function. Clinical histories of 134 HBV carriers with NHL who were treated with chemotherapy were obtained and analyzed for the occurrence of damaged liver function and other related high-risk factors. Analysis showed that 76 patients (56.7%) had damaged liver function after chemotherapy: 6 patients (7.9%) had I degree, 17 patients (22.4%) had II degree, 20 patients (26.3%) had III degree, and 33 patients (43.4%) had IV degree damage. After treatment, 18 patients (23.7%) continued to receive chemotherapy according to their original schedule, 39 patients (51.3%) delayed chemotherapy, 16 patients (21.1%) stopped chemotherapy, and 3 patients (3.9%) died. Analysis of a binary multivariate logistic regression model showed that administration of steroids was a high-risk factor for damaged liver function after chemotherapy in NHL patients. The incidence of damaged liver function after chemotherapy is high among HBV carriers with NHL; therefore, administration of steroid chemotherapy is a high-risk factor.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Hepatitis B/fisiopatología , Hígado/fisiopatología , Linfoma no Hodgkin/tratamiento farmacológico , Adolescente , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/virología , Niño , Femenino , Hepatitis B/complicaciones , Hepatitis B/virología , Virus de la Hepatitis B/fisiología , Interacciones Huésped-Patógeno , Humanos , Hígado/patología , Hígado/virología , Modelos Logísticos , Linfoma no Hodgkin/complicaciones , Masculino , Persona de Mediana Edad , Análisis Multivariante , Evaluación de Resultado en la Atención de Salud/métodos , Evaluación de Resultado en la Atención de Salud/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Adulto Joven
7.
Br Poult Sci ; 55(5): 653-61, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25109942

RESUMEN

The objective of the study was to investigate the differences in eggshell quality, bone quality and serum bone biochemistry markers associated with changes in age and dietary soybean oil levels in laying hens. A total of 54, 19-week-old Hy-Line Brown laying hens were housed in 18 battery cages (3 birds/cage) and randomly divided into three diet treatments for 90 d: control-fat (CF, 1.9% soybean oil), moderate-fat (MF, 7% soybean oil) and high-fat (HF, 10% soybean oil). The hens' body weights (BW), egg production, egg weights, eggshell thickness and femoral diameter were higher at d 90 than at d 60 or d 30. Meanwhile, feed intake, relative bone weights, all bone strength parameters and serum Ca were lower at d 90 or 60 than at d 30. Compared to the CF hens, the feed intake, BW, abdominal fat pad weights and serum alkaline phosphatase activity were elevated in MF or HF hens. The eggshell thickness, relative femoral and tibial weight, femoral stiffness, femoral modulus, tibial mixed force and serum calcium and phosphorus levels were lower in MF or HF hens than CF hens. These findings suggest that bone loss in caged hens starts from an early stage of the laying period, and dietary oil (particularly with diets over 10% soybean oil) has harmful effects on eggshell quality, bone strength and bone mineralisation from an early stage of the laying period.


Asunto(s)
Envejecimiento , Calcificación Fisiológica/efectos de los fármacos , Pollos/fisiología , Cáscara de Huevo/efectos de los fármacos , Aceite de Soja/metabolismo , Alimentación Animal/análisis , Animales , Análisis Químico de la Sangre/veterinaria , Dieta/veterinaria , Relación Dosis-Respuesta a Droga , Cáscara de Huevo/fisiología , Femenino , Distribución Aleatoria
8.
Genet Mol Res ; 13(1): 1314-22, 2014 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-24634229

RESUMEN

XRCC1 (human X-ray repair complementing defective repair in Chinese hamster cell 1) gene is considered a potentially important gene influencing the risk of hepatocellular carcinoma (HCC). Our analyses detected two allelic variants of XRCC1, c.910A>G and c.1686C>G. We aimed to investigate whether these polymorphisms influence the risk of HCC. The association between the XRCC1 polymorphisms and the risk of HCC was analyzed in 719 patients and 662 controls by polymerase chain reaction-restriction fragment length polymorphism. Our data suggested that the genotypes and alleles of c.910A>G and c.1686C>G polymorphisms were statistically associated with the risk of HCC. For c.910A>G, the GG genotype was associated with increased risk of developing HCC compared with the AA wild genotype (OR = 1.95, 95%CI = 1.40-2.70, P < 0.0001). For c.1686C>G, the risk of HCC was significantly higher for the GG genotype compared with the CC wild genotype (OR = 1.89, 95%CI = 1.375-2.599, P < 0.0001). Significant differences in the risk of HCC were also found with other genetic models for these two SNPs. The G allele of both c.910A>G and c.1686C>G may contribute to the risk of HCC (G versus A: OR = 1.40, 95%CI = 1.20-1.64, P < 0.0001 and G versus C: OR = 1.38, 95%CI = 1.19-1.61, P < 0.0001, respectively). Our findings suggest that the c.910A>G and c.1686C>G polymorphisms of XRCC1 are associated with the risk of HCC in the Chinese population.


Asunto(s)
Carcinoma Hepatocelular/genética , Proteínas de Unión al ADN/genética , Neoplasias Hepáticas/genética , Polimorfismo de Nucleótido Simple , Adenina/metabolismo , Anciano , Pueblo Asiatico/genética , Carcinoma Hepatocelular/patología , Estudios de Casos y Controles , Citosina/metabolismo , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Guanina/metabolismo , Humanos , Neoplasias Hepáticas/patología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Proteína 1 de Reparación por Escisión del Grupo de Complementación Cruzada de las Lesiones por Rayos X
9.
Environ Technol ; 34(5-8): 737-46, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23837325

RESUMEN

The aim of this study was to identify qualitative and quantitative changes in the character of water-extractable organic matter (WEOM) in soils as a consequence of soil aquifer treatment (SAT). Soil samples were obtained from a soil-column system with a 2-year operation, and divided into seven layers from top to bottom: CS1 (0-12.5 cm), CS2 (12.5-25 cm), CS3 (25-50 cm), CS4 (50-75 cm), CS5 (75-100 cm), CS6 (100-125 cm) and CS7 (125-150 cm). A sample of the original soil used to pack the columns was also analysed to determine the effects of SAT. Following 2 years of SAT operation, both soil organic carbon and water-extractable organic carbon were shown to accumulate in the top soil layer (0-12.5 cm), and to decrease in soil layers deeper than 12.5 cm. The WEOM in the top soil layer was characterized by low aromaticity index (AI), low emission humification index (HIX) and low fluorescence efficiency index (F(eff)). On the other hand, the WEOM in soil layers deeper than 12.5 cm had increased values of HIX and F(eff), as well as decreased AI values relative to the original soil before SAT. In all soil layers, the percentage of hydrophobic and transphilic fractions decreased, while that of the hydrophilic fraction increased, as a result of SAT. The production of the amide-2 functional groups was observed in the top soil layer. SAT operation also led to the enrichment of hydrocarbon and amide-1 functional groups, as well as the depletion of oxygen-containing functional groups in soil layers deeper than 12.5 cm.


Asunto(s)
Agua Subterránea/análisis , Compuestos Orgánicos/química , Compuestos Orgánicos/aislamiento & purificación , Suelo/química , Aguas Residuales/análisis , Contaminantes Químicos del Agua/química , Contaminantes Químicos del Agua/aislamiento & purificación , Agua Subterránea/química , Análisis Espectral/métodos , Purificación del Agua/métodos
10.
Shanghai Kou Qiang Yi Xue ; 9(4): 216-7, 2000 Dec.
Artículo en Chino | MEDLINE | ID: mdl-15014762

RESUMEN

OBJECTIVE: To determine the sintering temperature range and the best temperature of coloration of HN-97 porcelain stain,and matched porcelain powders. METHODS: (1) The authors used prepared experiments of sintering temperatures and different sintering temperatures with different porcelain powders. RESULTS: The results showed sintering temperature range of the stain was 820-955 degrees centigrade; (2)The stain can be matched with many porcelain powders (e.g.Vita,Densply. Shofu and Shanghai); (3)Surface of stain was smooth, colour was stable,integrate was good. CONCLUSION: The stain can be used once coloration and glaze for restoration of porcelain, autoglazing temperature of which is between 820-955 degrees centigrade and the operation is easy.

11.
Proc Natl Acad Sci U S A ; 94(7): 3240-4, 1997 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-9096377

RESUMEN

The A-myb gene is a transcription factor that shares structural and functional similarities with the v-myb oncogene. To date, v-myb is the only myb gene directly implicated in tumorigenesis, a property attributed to its transactivating ability. Recent studies have demonstrated that A-myb, like v-myb, is a potent transcriptional activator, raising the possibility that A-myb may also participate in oncogenesis. To test this hypothesis, we generated fusion constructs that contained the human A-myb cDNA under control of the mouse metallothionein promoter and the mouse mammary tumor virus long terminal repeat. These constructs were inserted into the germ line of mice, and the functional consequences of ectopic A-myb expression were examined. Although transgene expression was detected in a wide range of tissues, abnormalities were confined primarily to hematopoietic tissues. After a 9-month latency, A-myb transgenic mice developed hyperplasia of the spleen and lymph nodes. Enlarged tissues contained a polyclonally expanded B lymphocyte population that expressed a germinal center-cell phenotype. Transgenic B lymphocytes showed increased DNA synthesis in response to low dose mitogen stimulation, suggesting that A-myb may contribute to hyperplasia by increasing the rate of B cell proliferation.


Asunto(s)
Linfocitos B/citología , División Celular/genética , Hiperplasia/genética , Oncogenes , Animales , Humanos , Tejido Linfoide/patología , Ratones , Ratones Transgénicos
12.
Cancer Res ; 54(24): 6512-6, 1994 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-7987850

RESUMEN

A partial-length A-myb complementary DNA recently cloned by low-stringency hybridization with a c-myb probe to complementary DNA libraries derived from human cell lines showed a high degree of homology with the DNA-binding domain of c-myb and B-myb, suggesting that A-myb also encoded a DNA-binding protein. We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-A-myb fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with Myb-binding sites of the c-myb responsive promoters, MIM-1 and CD34. In transient transfection assays, A-myb transactivated the bound promoters. These results suggest that, analogous to the other members of the Myb family, the A-myb gene encodes a bona fide transactivator. The distinct function of A-myb might derive from its pattern of expression and/or its relative potency as a transactivator of myb target genes.


Asunto(s)
ADN Complementario/genética , Genes Reguladores/genética , Oncogenes/genética , Proteínas Proto-Oncogénicas/genética , Transactivadores/genética , Secuencia de Aminoácidos , Secuencia de Bases , Cloranfenicol O-Acetiltransferasa/genética , Cloranfenicol O-Acetiltransferasa/metabolismo , ADN Complementario/fisiología , Genes Reguladores/fisiología , Genes Reporteros/genética , Humanos , Datos de Secuencia Molecular , Oncogenes/fisiología , Proteínas Proto-Oncogénicas/química , Proteínas Proto-Oncogénicas/fisiología , Transactivadores/química , Transactivadores/fisiología
13.
Shanghai Kou Qiang Yi Xue ; 3(4): 203-4, 1994 Dec.
Artículo en Chino | MEDLINE | ID: mdl-15160125
14.
Biomed Environ Sci ; 4(3): 273-82, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1764217

RESUMEN

The effect of 23 sodium alginate preparations from different species of algae (Sargassum sp.) and kelp (Laminaria sp.) on reducing the absorption of strontium was studied in detail. A pilot production procedure has been established. Na alginate from S. siliquastrum was proven to be a potent agent for reducing Sr absorption, with high efficiency and virtually no toxicity. It reduced the body burden of strontium 3.3-4.2 fold in rats. Strontium absorption in human subjects was reduced by 78% (+/- 8.9) or completely suppressed the increase of serum Sr at 2 h after ingestion of stable Sr in volunteers and decrease 24 h urine Sr to similar extent. No undesirable effects on gastrointestinal function was observed nor were Ca, Fe, Cu and Zn metabolism changed, both in the animal experiments and in human. It was concluded that alginate preparations derived from Sargassum species are a suitable antidote against radiostrontium absorption on a long-term basis, when added to bread at a 6% level. In cases of emergency, an alginate syrup preparation appears to be more suitable because of its rapid action.


Asunto(s)
Alginatos/farmacología , Protectores contra Radiación/farmacología , Radioisótopos de Estroncio/farmacocinética , Alginatos/aislamiento & purificación , Alginatos/toxicidad , Animales , Gatos , Eucariontes/química , Ácido Glucurónico , Ácidos Hexurónicos , Humanos , Absorción Intestinal/efectos de los fármacos , Intubación Gastrointestinal , Protectores contra Radiación/aislamiento & purificación , Protectores contra Radiación/toxicidad , Ratas , Ratas Endogámicas
15.
Ann Surg ; 195(6): 766-73, 1982 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7082068

RESUMEN

For decades, the preparation of a hyperthyroid patient for surgery took several weeks or months utilizing thyroid blocking agents and iodine. In 1973, a preliminary report of 20 patients with hyperthyroidism treated with propranolol and thyroidectomy was presented. It was found that a thyrotoxic patient could be prepared for surgery, in an emergency, by intravenous propranolol in less than an hour, or electively by oral propranolol within 24 hours. Since then, 140 additional patients have been similarly treated. It continues to be true at this institution that propranolol, a beta-adrenergic blocking agent, effectively neutralizes the symptoms of autonomic hyperactivity, including sweating, tremor, fever, dilation of blood vessels, and increased pulse rate without significantly affecting thyroid function. An average dose of 160 mg/day was used, with a range of 40 to 320 mg/day. In none of these patients was iodine used; in fact, its use with propranolol is considered unnecessary. A subtotal, near total, or total thyroidectomy was done in all patients, resulting in a 55% incidence of hypothyroidism. There was no postoperative thyroid storm, nerve injury, or permanent hypoparathyroidism. It is believed that the administration of propranolol alone provides a rapid, safe, and effective preparation of the thyrotoxic patient for thyroidal or extrathyroidal surgical procedures during the perioperative period.


Asunto(s)
Hipertiroidismo/tratamiento farmacológico , Propranolol/uso terapéutico , Tiroidectomía , Adolescente , Adulto , Anciano , Enfermedades de los Nervios Craneales/etiología , Femenino , Humanos , Hipertiroidismo/etiología , Hipertiroidismo/cirugía , Hipotiroidismo/etiología , Periodo Intraoperatorio , Yodo/uso terapéutico , Nervios Laríngeos , Masculino , Persona de Mediana Edad , Glándulas Paratiroides/cirugía , Complicaciones Posoperatorias , Periodo Posoperatorio , Propranolol/efectos adversos , Propranolol/farmacología , Tiroidectomía/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA